The effects of platelet-activating factor (PAF) were studied on isolated feline basilar arteries (BAs) and human pial arteries (PAs). PAF contracted the BAs by 67% of the contraction induced by 124 mM K+ and the PAs by 80%. The contraction in BAs was unaffected by both indomethacin and the thromboxane receptor antagonist AH23848. PAF relaxed prostaglandin F2α-contracted arteries. In BAs 10−6M PAF reduced the contraction by 17% and in PAs by 47%. The relaxant effects in both arteries were unaffected by indomethacin. In conclusion, PAF can act both as a constrictor and as a dilator of isolated feline and human cerebral arteries. The effects are seemingly unrelated to vascular prostanoid production.
ArmsteadWMPourcyrousMMirroRLefflerCWBusijaDW, (1988) Platelet activating factor: A potent constrictor of cerebral arterioles in newborn pigs. Circ Res62:1–7
2.
BraquetPTouquiLShenTYVargaftigBB, (1987) Perspectives in platelet-activating factor research. Pharmacol Rev39:97–145
3.
BrittainRTBoutalLCarterMCColemanRACollingtonEWGeishowHPHalletPHornbyEJHumphreyPPAJackDKennedyILumleyPMcCabePJSkidmoreIFThomasMWallisCJ, (1985) AH23848: A thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2. Circulation72:1208–1218
4.
GoldsteinREEzraDLaurindoFRMFeuersteinGZ, (1986) Coronary and pulmonary vascular effects of leukotrienes and PAF-acether. Pharmacol Res Commun18:151–162
5.
HögestättEDAnderssonK-EEdvinssonL, (1983) Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand117:49–61
6.
KochanekPMNemotoEMMelickJAEvansRWBurkeDF, (1988) Cerebrovascular and cerebrometabolic effects of intracarotid infused platelet-activating factor in rats. J Cereb Blood Flow Metab8:546–551
7.
MehtaJWargovichTNicholsWW, (1986) Biphasic effects of platelet-activating factor on coronary blood flow in anesthetized dog. Prostaglandins Leukotrienes Med21:87–95
8.
MoncadaSHermanAGHiggsEAVaneJR, (1977) Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the antithrombotic properties of vascular endothelium. Thromb Res11:323–344
9.
PanettaTMarcheselliVLBraquetPSpinnewynBBazanNG, (1987) Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: Inhibition of ischemic-reperfusion induced cerebral injury. Biochem Biophys Res Commun149:580–587
10.
SpinnewynBBlavetNClostreFBazanNBraquetP, (1987) Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in mongolian gerbils. Prostaglandins34:337–349
11.
StahlGLLeferAM, (1987) Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators. Blood Vessels24:24–30
12.
UskiTK, (1988) Further characterization of the contraction-mediating prostanoid receptors in feline cerebral arteries. Effects of the thromboxane-receptor antagonist AH23848. Acta Physiol Scand133:519–534
13.
VaneJR, (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature231:232–235
